Photo by finnnyc from unsplash
Abstract Dual anti-platelet therapy is prescribed in the setting of coronary heart disease for the prevention of stent thrombosis and acute thrombotic events. The optimal duration of dual anti-platelet therapy… Click to show full abstract
Abstract Dual anti-platelet therapy is prescribed in the setting of coronary heart disease for the prevention of stent thrombosis and acute thrombotic events. The optimal duration of dual anti-platelet therapy is still under debate as numerous trials have shown non-inferiority of a strategy of early cessation of one of the agents as compared to the standard practice whereas two larger trials have demonstrated benefit of prolonging dual anti-platelet therapy.
Keywords:
anti platelet;
dual anti;
platelet therapy;
duration dual
Journal Title: Acta Cardiologica
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Acta Cardiologica
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!